Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Abbott Laboratories (ABT)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Abbott Labs's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
107.60 +0.53    +0.49%
16:00:01 - Closed. Currency in USD ( Disclaimer )
After Hours
107.99
+0.39
+0.36%
17:33:15 - Real-time Data
  • Volume: 3,638,345
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 107.31 - 108.10
Type:  Equity
Market:  United States
Abbott Labs 107.60 +0.53 +0.49%

ABT Balance Sheet

 
Featured here, the Balance Sheet for Abbott Laboratories, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Collapse All
Period Ending: 2024
31/03
 2023
31/12
 2023
30/09
 2023
30/06
Total Current Assets - 22670 22664 23505
Cash and Short Term Investments - 7279 7047 8155
Cash - - - -
Cash & Equivalents - 6896 6709 7835
Short Term Investments - 383 338 320
Total Receivables, Net - 6565 6499 6172
Accounts Receivables - Trade, Net - 6565 6499 6172
Total Inventory - 6570 6650 6871
Prepaid Expenses - 2087 2101 2082
Other Current Assets, Total - 169 367 225
Total Assets - 73214 72090 73354
Property/Plant/Equipment, Total - Net - 11276 9552 9449
Property/Plant/Equipment, Total - Gross - 23055 21111 20926
Accumulated Depreciation, Total - -11779 -11559 -11477
Goodwill, Net - 23679 23277 23258
Intangibles, Net - 8815 9282 9834
Long Term Investments - 485 497 494
Note Receivable - Long Term - - - -
Other Long Term Assets, Total - 6289 6818 305
Other Assets, Total - 557 856 7753
Total Current Liabilities - 13841 13042 14350
Accounts Payable - 4295 3961 4211
Payable/Accrued - - - -
Accrued Expenses - 6543 6635 6505
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases - 1325 1064 2284
Other Current liabilities, Total - 1678 1382 1350
Total Liabilities - 34387 34396 35950
Total Long Term Debt - 13599 14635 14704
Long Term Debt - 13599 14635 14704
Capital Lease Obligations - - - -
Deferred Income Tax - 568 - -
Minority Interest - 224 213 230
Other Liabilities, Total - 5736 6105 6253
Total Equity 38827 38827 37694 37404
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total - 24869 24727 24612
Additional Paid-In Capital - - - -
Retained Earnings (Accumulated Deficit) - 37554 36920 36355
Treasury Stock - Common - -15981 -15686 -15722
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 38827 -7615 -8267 -7841
Total Liabilities & Shareholders' Equity - 73214 72090 73354
Total Common Shares Outstanding 1734.08 1734.08 1736.06 1735.36
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

ABT Comments

Write your thoughts about Abbott Laboratories
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
grant mclean
grant mclean Dec 22, 2021 15:19
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
anyone watching
Reply
0 0
Report
Larry Taylor
Larry Taylor Jan 25, 2021 10:25
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Going to $120
Reply
0 0
Report
Larry Taylor
Larry Taylor Jan 25, 2021 10:24
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Going to $120
Reply
0 0
Report
nikhil bhardwaj
nikhil bhardwaj Apr 16, 2020 8:28
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Dropping to low 80s on a bad earnings then maybe rebound
Reply
1 5
Report
grant mclean
grant mclean Apr 16, 2020 8:28
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
so much for that prediction
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email